Alerts will be sent to your verified email
Verify EmailUNJHAFOR
Unjha Formulations
|
Decipher Labs
|
Venmax Drugs&Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
11.14 % | 9.38 % | -44.32 % |
5yr average Equity Multiplier
|
1.74 | 2.01 | -0.19 |
5yr Average Asset Turnover Ratio
|
3.48 | 1.29 | 0.32 |
5yr Avg Net Profit Margin
|
1.88 % | 2.8 % | -30.94 % |
Price to Book
|
3.5 | 0.48 | 2.72 |
P/E
|
25.89 | 0.0 | 0.0 |
5yr Avg Cash Conversion Cycle
|
14.25 Days | -270.54 Days | 0.0 |
Inventory Days
|
26.1 Days | 1.26 Days | 24.83 Days |
Days Receivable
|
26.23 Days | 89.79 Days | 0.0 |
Days Payable
|
63.08 Days | 3118.67 Days | 189.56 Days |
5yr Average Interest Coverage Ratio
|
5.17 | 4.09 | -318.36 |
5yr Avg ROCE
|
20.73 % | 12.42 % | -45.33 % |
5yr Avg Operating Profit Margin
|
2.93 % | 1.0 % | -50.41 % |
5 yr average Debt to Equity
|
0.0 | 0.46 | -0.64 |
5yr CAGR Net Profit
|
-2.02 % | n/a | n/a |
5yr Average Return on Assets
|
6.49 % | 3.79 % | 187.49 % |
Shareholdings
|
|||
Promoter Holding
|
36.92 % | 16.43 % | 23.13 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -17.76 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Unjha Formulations
|
Decipher Labs
|
Venmax Drugs&Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|